Chronic kidney disease trials in Norway

In Norway 6 Also abroad 798

6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Bergen, Loerenskog
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Drammen, Grålum, Skien
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Bergen, Bodo, Drammen, Foerde, Gjettum, Graalum, Haugesund, Levanger, Loerenskog, Oslo, Skedsmokorset, Skien, Stavanger, Toensberg, Tromsoe, Trondheim
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 3Taking people
SACK
Where
Bergen, Drammen, Lorenskog, Oslo, Stavanger, Tonsberg, Tromsoe, Trondheim
Age
18 years and over
People
1,281 worldwide
Run by
Karolinska University Hospital
See details and how to join2022-501600-10-00 · EU 2022-501600-10-00
No phaseNot yet taking people in Norway
The Intravenous Amino Acid Therapy for Vascular Rigidity in End Stage Renal Disease
Where
Bergen
People
120
Run by
Haukeland University Hospital
See details and how to joinNCT07392697
Phase 3Taking people
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Where
Oslo, Stavanger, Tønsberg, Tromsø
Age
18 years and over
People
1,400 worldwide
Run by
Region Stockholm
See details and how to joinNCT05679024